GALNTL5 and breast carcinoma: (F-J) Survival analysis was performed for GALNTL5, MLIP, HMCN2, LRRN4CL and DUOX2 using log-rank test for RNA-seq data and the corresponding survival data from the TCGA cohort of patients with breast cancer.